ClinicalTrials.Veeva

Menu

Optimal Site of Administration for Continuous Wound Infusion After Cesarean Section

A

Association pour la Recherche et la Formation en Anesthésie Analgésie Réanimation

Status and phase

Completed
Phase 3

Conditions

Cesarean Section

Treatments

Procedure: Continuous wound
Procedure: Continuous wound infusion

Study type

Interventional

Funder types

Other

Identifiers

NCT01160913
KTCESAR

Details and patient eligibility

About

The purpose of this randomized double-blind study is to evaluate in which anatomical layer (AF versus BF) continuous wound infusion of local anesthetics combined with NSAIDs through a multiorifice catheter has the best effectiveness during the first 48 hours on postoperative pain intensity after elective cesarean delivery.

Enrollment

56 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • elective Cesarean Section under spinal anesthesia over37 weeks' gestation

Exclusion criteria

  • allergy to NSAIDs
  • ASA III or higher
  • refusal to participate

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

56 participants in 2 patient groups

Continuous wound infusion above the fascia
Active Comparator group
Treatment:
Procedure: Continuous wound infusion
Continuous wound infusion below the fascia
Active Comparator group
Treatment:
Procedure: Continuous wound

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems